Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fiasp in 670G Hybrid Closed-Loop Therapy
NCT03554486Phase 4Completed
- Sponsor
- Stanford University
- Start
- Jul 2018
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by Stanford University. Started Jul 2018; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03554486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03554486.